Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on…

By B. Levin, D. Lieberman, B. McFarland, Robert A Smith, D. Brooks, Kimberly S. Andrews, C. Dash, F. Giardiello, S. Glick, T. Levin and 4 more. Ca, 2008

3,291 citations recorded by the source corpus.

In the United States, colorectal cancer (CRC) is the third most common cancer diagnosed among men and women and the second leading cause of death from cancer. CRC largely can be prevented by the detection and removal of adenomatous polyps, and survival is significantly better when CRC is diagnosed while still localized. In 2006 to 2007, the American Cancer Society, the US Multi Society Task Force on Colorectal Cancer, and the American College of Radiology came together to develop consensus guidelines for the detection of adenomatous polyps and CRC in asymptomatic average‐risk adults. In this update of each organization's guidelines, screening tests are grouped into those that primarily detect cancer early and those that can detect cancer early and also can detect adenomatous polyps, thus providing a greater potential for prevention through polypectomy. When possible, clinicians should make patients aware of the full range of screening options, but at a minimum they should be prepared to offer patients a choice between a screening test that is effective at both early cancer detection and cancer prevention through the detection and removal of polyps and a screening test that primarily is effective at early cancer detection. It is the strong opinion of these 3 organizations that colon cancer prevention should be the primary goal of screening.

Subfields: Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/79fb501661cac6a36bbe2d136befb3ddedd4417e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

In Pathology and Forensic Medicine

Citations in the corpus

Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society (2018, methodology): “The most recent update of recommendations for individuals at average risk occurred in 2008 and was based on an evidence-based consensus process that included the ACS, the US MultiSociety Task Force (USMSTF) on Colorectal Cancer (representing the American College of Gastroenterology, the American Gas”
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer (2017, background): “The main risk factor for colorectal cancer is age: past the fifth decade of life, the risk of developing CRC is markedly increased, while the onset of colorectal cancer below the age of fifty is rare (apart from inherited cancers) [13].”
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths (2012, neutral): “0 Splenic flexure (1), ascending (5) 1 70 12”
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer (2010, background): “However, no single test or strategy for CRC screening can be endorsed on the basis of currently available data; and several approaches are included as options in the screening guidelines.(4) Colonoscopy is currently the most reliable screening tool for CRC; the invasive nature brings about low adher”
Quality Indicators for Colonoscopy (2015, positive): “In the average-risk population (persons aged R50 years without other risk factors for CRC or who have only one first-degree relative with CRC and that cancer was diagnosed at age O60 years), colonoscopic screening is recommended in all past and current guidelines at 10-year intervals.(15,47,48) A Ge”